胍法辛治疗老年患者的易怒、冲动和激动：两例报告。
Guanfacine for irritability, impulsivity, and agitation in elderly patients: A report of two cases.
作者信息
Miyoshi Takafumi, Noborio Yayoi, Hoonhwa Chang, Ishimori Yuki
机构信息
Department of Psychiatry Itami City Hospital, Itami-shi Hyogo Japan.
Department of Nursing Itami City Hospital, Itami-shi Hyogo Japan.
出版信息
PCN Rep. 2022 May 18;1(2):e14. doi: 10.1002/pcn5.14. eCollection 2022 Jun.
Abstract
BACKGROUND
Irritability, impulsivity, and agitation in elderly patients with dementia are highly prevalent and extremely burdening for patients, caregivers, and medical staff. In general hospitals, they have been one of the major problems that develop and disturb care and treatment. However, the mechanisms underlying these symptoms remain unclear, and there is no established treatment. In actual clinical practice, antipsychotic drugs and mood stabilizers have been mainly used as pharmacotherapies for these symptoms, but adverse effects of these drugs have often been problematic.
CASE PRESENTATION
We report two valuable cases of elderly patients who were admitted to our hospital due to physical disorders and developed irritability, impulsivity, and agitation, which were effectively treated with guanfacine at very low doses and in a short period.
CONCLUSION
The present cases suggest that guanfacine may be a therapeutic option for treating irritability, impulsivity, and agitation in elderly patients.
摘要
背景
老年痴呆患者的易激惹、冲动和激越现象非常普遍，给患者、照料者和医护人员带来极大负担。在综合医院，这些现象一直是影响和干扰护理及治疗的主要问题之一。然而，这些症状背后的机制仍不清楚，且尚无既定的治疗方法。在实际临床实践中，抗精神病药物和心境稳定剂一直是治疗这些症状的主要药物疗法，但这些药物的不良反应常常成为问题。
病例报告
我们报告两例有价值的老年患者病例，他们因躯体疾病入院，出现了易激惹、冲动和激越症状，通过极低剂量且短期使用胍法辛得到了有效治疗。
结论
目前的病例表明，胍法辛可能是治疗老年患者易激惹、冲动和激越的一种治疗选择。
相似文献
1
Guanfacine for irritability, impulsivity, and agitation in elderly patients: A report of two cases.胍法辛治疗老年患者的易怒、冲动和激动：两例报告。
PCN Rep. 2022 May 18;1(2):e14. doi: 10.1002/pcn5.14. eCollection 2022 Jun.
2
Considerations and Current Trends in the Management of the Geriatric Patient on a Consultation-Liaison Service.老年患者在联络会诊服务中的管理注意事项和当前趋势。
Curr Psychiatry Rep. 2020 Apr 13;22(5):21. doi: 10.1007/s11920-020-01147-2.
3
Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.丙戊酸镁缓释片用于治疗痴呆的行为和心理症状的开放标签前瞻性研究报告：单药治疗及与第二代抗精神病药物联合治疗
Am J Geriatr Pharmacother. 2007 Sep;5(3):209-17. doi: 10.1016/j.amjopharm.2007.09.001.
4
Effects of cariprazine on reducing symptoms of irritability, hostility, and agitation in patients with manic or mixed episodes of bipolar I disorder.卡利拉嗪对改善双相 I 型障碍躁狂或混合发作患者激惹、敌意和激越症状的效果。
J Affect Disord. 2024 Aug 1;358:353-360. doi: 10.1016/j.jad.2024.04.084. Epub 2024 Apr 22.
5
Treating impulsivity, irritability, and aggression of antisocial personality disorder with quetiapine.使用喹硫平治疗反社会人格障碍的冲动性、易怒和攻击性。
Int J Offender Ther Comp Criminol. 2003 Oct;47(5):556-67. doi: 10.1177/0306624X03253027.
6
Prevalence and clinical significance of subsyndromal manic symptoms, including irritability and psychomotor agitation, during bipolar major depressive episodes.双相重性抑郁发作时亚综合征性躁狂症状（包括易激惹和精神运动激越）的发生率和临床意义。
J Affect Disord. 2012 May;138(3):440-8. doi: 10.1016/j.jad.2011.12.046. Epub 2012 Feb 6.
7
The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present.自闭症谱系障碍的儿科精神药理学：系统评价 - 第一部分：过去和现在。
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Aug 30;110:110326. doi: 10.1016/j.pnpbp.2021.110326. Epub 2021 Apr 20.
8
Anxiety, irritability, and agitation as indicators of bipolar mania with depressive symptoms: a post hoc analysis of two clinical trials.焦虑、易怒和激越作为伴有抑郁症状的双相躁狂的指标：两项临床试验的事后分析
Int J Bipolar Disord. 2017 Nov 6;5(1):36. doi: 10.1186/s40345-017-0103-7.
9
10
Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes: A cluster-randomised controlled trial.以人为主的照护训练和活动对养老院老年痴呆患者生活质量、激越和抗精神病药物使用的影响：一项整群随机对照试验。
PLoS Med. 2018 Feb 6;15(2):e1002500. doi: 10.1371/journal.pmed.1002500. eCollection 2018 Feb.
引用本文的文献
1
Noradrenergic therapies in neurodegenerative disease: from symptomatic to disease modifying therapy?神经退行性疾病中的去甲肾上腺素能疗法：从对症治疗到疾病修饰治疗？
Brain Commun. 2025 Aug 25;7(5):fcaf310. doi: 10.1093/braincomms/fcaf310. eCollection 2025.
2
Efficacy of Guanfacine for Self-injurious and Aggressive Behaviors through the Reduction of Impulsivity in Borderline Personality Disorder: Two Case Reports and a Literature Review.通过降低边缘型人格障碍的冲动性来观察胍法辛对自伤和攻击行为的疗效：两例病例报告及文献综述
Clin Psychopharmacol Neurosci. 2025 Aug 31;23(3):520-525. doi: 10.9758/cpn.24.1263. Epub 2025 Mar 17.
3
Guanfacine for the management of the behavioral manifestations of delirium in older hospitalized adults.胍法辛用于管理老年住院患者谵妄的行为表现。
Ment Health Clin. 2025 Jun 2;15(3):164-169. doi: 10.9740/mhc.2025.06.164. eCollection 2025 Jun.
4
Case series: Potential use of guanfacine for safer management of behavioral disturbances in patients with dementia.病例系列：胍法辛在更安全管理痴呆患者行为障碍方面的潜在用途。
PCN Rep. 2025 May 19;4(2):e70122. doi: 10.1002/pcn5.70122. eCollection 2025 Jun.
本文引用的文献
1
Research Criteria for the Behavioral Variant of Alzheimer Disease: A Systematic Review and Meta-analysis.阿尔茨海默病行为变异型的研究标准：系统评价和荟萃分析。
JAMA Neurol. 2022 Jan 1;79(1):48-60. doi: 10.1001/jamaneurol.2021.4417.
2
Efficacy of combination therapy with gabapentin and guanfacine for paroxysmal sympathetic hyperactivity following hypoxic encephalopathy: a case report.加巴喷丁与胍法辛联合治疗缺氧性脑病后阵发性交感神经过度兴奋的疗效：一例报告
J Int Med Res. 2021 Apr;49(4):3000605211009721. doi: 10.1177/03000605211009721.
3
Guanfacine for Hyperactive Delirium: A Case Series.胍法辛治疗多动性谵妄：病例系列
J Acad Consult Liaison Psychiatry. 2021 Jan-Feb;62(1):83-88. doi: 10.1016/j.psym.2020.10.003. Epub 2020 Nov 13.
4
Late-onset attention-deficit/hyperactivity disorder as a differential diagnosis of dementia: a case report.迟发性注意缺陷/多动障碍作为痴呆的鉴别诊断：病例报告。
BMC Psychiatry. 2020 Nov 23;20(1):550. doi: 10.1186/s12888-020-02949-7.
5
Efficacy and Safety of Guanfacine Extended-Release in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled Study.胍法辛缓释剂治疗成人注意缺陷多动障碍的疗效和安全性：一项随机、双盲、安慰剂对照研究的结果。
J Clin Psychiatry. 2020 Apr 14;81(3):19m12979. doi: 10.4088/JCP.19m12979.
6
The influence of the individual neuropsychiatric symptoms of people with Alzheimer disease on family caregiver distress-A longitudinal ALSOVA study.阿尔茨海默病患者个体神经精神症状对家庭照顾者痛苦的影响——一项纵向ALSOVA研究
Int J Geriatr Psychiatry. 2018 May 30. doi: 10.1002/gps.4911.
7
Galantamine Response Associates with Agitation and the Prefrontal Cortex in Patients with Alzheimer's Disease.加兰他敏反应与阿尔茨海默病患者的激越及前额叶皮质相关。
J Alzheimers Dis. 2017;57(1):267-273. doi: 10.3233/JAD-160902.
8
Neuroimaging Findings Related to Behavioral Disturbances in Alzheimer's Disease: A Systematic Review.阿尔茨海默病中与行为障碍相关的神经影像学研究结果：一项系统综述。
Curr Alzheimer Res. 2017;14(1):61-75. doi: 10.2174/1567205013666160603010203.
9
Adjunctive treatment with high frequency repetitive transcranial magnetic stimulation for the behavioral and psychological symptoms of patients with Alzheimer's disease: a randomized, double-blind, sham-controlled study.高频重复经颅磁刺激辅助治疗阿尔茨海默病患者的行为和心理症状：一项随机、双盲、假刺激对照研究。
Shanghai Arch Psychiatry. 2015 Oct;27(5):280-8. doi: 10.11919/j.issn.1002-0829.215107.
10
Stress weakens prefrontal networks: molecular insults to higher cognition.压力会削弱前额叶网络：对高级认知的分子损伤。
Nat Neurosci. 2015 Oct;18(10):1376-85. doi: 10.1038/nn.4087. Epub 2015 Sep 25.
Zotero 插件